Tag: Cancer: Lung
Most Lung Cancer-Specific Tweets Relate to Support, Prevention
<20 percent of tweets about clinical trials; only one tweet linked to a patient recruitment website
PET Scans May Be Overused in Monitoring of Cancer Survivors
Study finds using costly test as first option for follow-up may not improve survival
Cola Intake Increases Exposure of Erlotinib
Findings in patients treated with esomeprazole; likely due to pH-dependent solubility
Adjuvant Therapy Ups Survival in Small-Cell Lung Cancer
Improved survival for chemotherapy with or without cranial irradiation versus surgery alone
Weight Appears to Impact Outcomes Post Lung CA Surgery
Both underweight and very obese had the highest odds for complications
Support for First-Line Erlotinib in NSCLC With EGFR Mutations
And erlotinib therapy beyond progression may delay salvage tx for some patients
Modifiable Factors Affect Racial Differences in Lung Cancer
No racial/ethnic differences in the risk of lung cancer death among women in fully adjusted models
Pembrolizumab Shows Promise in Metastatic NSCLC
In study, the immune-based therapy beat docetaxel with fewer side effects
Age at NSCLC Diagnosis Tied to Odds of Targetable Phenotype
Younger age at diagnosis linked to increased frequency of targetable phenotype
Toxic Skin Effects Common With EGFR-TKI Use in NSCLC
Afatinib therapy linked to earlier paronychia onset; more dermatological visits for skin toxic effects
